A detailed history of Hilton Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hilton Capital Management, LLC holds 12,800 shares of LLY stock, worth $11.6 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
12,800
Previous 13,462 4.92%
Holding current value
$11.6 Million
Previous $7.85 Million 26.89%
% of portfolio
0.91%
Previous 0.86%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $392,036 - $524,489
-662 Reduced 4.92%
12,800 $9.96 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $470,045 - $554,121
895 Added 7.12%
13,462 $7.85 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $5.46 Million - $7.53 Million
12,567 New
12,567 $6.75 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hilton Capital Management, LLC Portfolio

Follow Hilton Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilton Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hilton Capital Management, LLC with notifications on news.